搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
6 小时
US Supreme Court Wrestles With FDA Denial of Flavored Vape Products
Triton and Vapetasia filed FDA applications in 2020 for products with flavors including sour grape, pink lemonade and crème ...
12 小时
on MSN
US Supreme Court examines FDA denial of flavored vape products
The U.S. Supreme Court began hearing arguments on Monday in the U.S. Food and Drug Administration's defense of the agency's ...
3 小时
on MSN
US salmonella outbreak linked to cucumbers under investigation by FDA and CDC
The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention are investigating a multistate ...
5 小时
Applied Therapeutics says it received FDA's warning letter for genetic disease drug study
Applied Therapeutics said on Monday it received a warning letter limited to a trial studying its genetic disease drug, after ...
MM&M
5 小时
Supreme Court leans toward FDA in oral arguments of landmark vaping case
In the ongoing case, vaping companies argue that the FDA was “arbitrary and capricious” in rejecting applications for ...
3 小时
Justices unconvinced of arguments against FDA’s flavored vape ban
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Justices unconvinced of arguments ...
1 小时
Supreme Court grapples with FDA's refusal to approve flavored vapes
As e-cigarettes have flooded the market, the FDA's role in approving new tobacco products is put under a microscope.
腾讯网
7 天
特朗普FDA局长人选被视为主要盟友 Hims & Hers Health(HIMS.US)飙至新高
智通财经APP获悉,亨特布鲁克传媒公司(Hunterbrook Media)表示,Hims & Hers Health(HIMS.US)将成为当选总统唐纳德·特朗普提名马蒂·马卡里(Marty ...
The American Journal of Managed Care
4 小时
Cancer Drug Prices Rise in the US Post-Launch, Fall in Germany, Switzerland
The median launch prices in the US increased from $29,630 (IQR, $1322-$49,691) for drugs approved in 201 to $84,240 (IQR, ...
腾讯网
13 天
FDA接受Aldeyra Therapeutics(ALDX.US)潜在“first-in-class”干眼症疗法上市申请
智通财经APP获悉,Aldeyra ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈